Enigma Diagnostics Limited - Product Pipeline Analysis, 2016 Update

Date: March 16, 2016
Pages: 31
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E9043CBD1C1EN
Leaflet:

Download PDF Leaflet

Enigma Diagnostics Limited - Product Pipeline Analysis, 2016 Update
Summary

Enigma Diagnostics Limited (Enigma) is a medical device company that offers diagnostic instrument. The company manufactures and markets molecular diagnostic instruments for detection and identification of infectious organisms. It develops molecular diagnostic instrument platforms. Enigma develops Enigma Mini Laboratory system which combines the speed and sensitivity of polymerase chain reaction. The company has pipeline of multiplexed assays for sexually transmitted diseases, respiratory diseases, and hospital acquired infections. It offers real-time PCR diagnostic testing for laboratories, local hospitals, at point-of-care locations. The company operates in the US and the UK. Enigma is headquartered in Salisbury, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Enigma Diagnostics Limited
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • Enigma Diagnostics Limited Company Snapshot
    Enigma Diagnostics Limited Company Overview
    Enigma Diagnostics Limited Pipeline Products and Clinical Trials Overview
    Enigma Diagnostics Limited – Pipeline Analysis Overview
    Key Facts
    Enigma Diagnostics Limited - Major Products and Services
    Enigma Diagnostics Limited Pipeline Products by Development Stage
    Enigma Diagnostics Limited Pipeline Products Overview
    Enigma ML - C. Difficile/Norovirus
    Enigma ML - C. Difficile/Norovirus Product Overview
    Enigma ML - CT/NG
    Enigma ML - CT/NG Product Overview
    Enigma ML - HPV
    Enigma ML - HPV Product Overview
    Enigma ML - MRSA
    Enigma ML - MRSA Product Overview
    Enigma ML - Rhinovirus
    Enigma ML - Rhinovirus Product Overview
    Enigma ML - Tuberculosis DST Detestion Assay
    Enigma ML - Tuberculosis DST Detestion Assay Product Overview
    Enigma ML System
    Enigma ML System Product Overview
    Enigma ML System - FluAB-RSV Diagnostic Assay
    Enigma ML System - FluAB-RSV Diagnostic Assay Product Overview
    Enigma XL System
    Enigma XL System Product Overview
    MDx Infectious Disease Assay
    MDx Infectious Disease Assay Product Overview
    ResonSense MDR-TB Assay
    ResonSense MDR-TB Assay Product Overview
    Enigma Diagnostics Limited - Key Competitors
    Enigma Diagnostics Limited - Key Employees
    Enigma Diagnostics Limited - Locations And Subsidiaries
    Head Office
    Recent Developments
    Enigma Diagnostics Limited, Recent Developments
    Jan 14, 2014: Enigma Diagnostics CE marks the Enigma ML system and its first multiplexed assay detecting Influenza A, Influenza B and RSV
    Jul 29, 2013: Enigma Diagnostics Announces Successful Completion of Flagship Enigma ML System Evaluation at Guy's and St. Thomas' NHS Foundation Trust, London, UK
    Dec 07, 2012: Enigma Diagnostics receives Biomedical Catalyst grant to develop multi drug resistant TB assay using proprietary ResonSense technology
    Jul 18, 2011: Enigma Completes RANGER Project Based On Enigma ML-Influenza A/B
    Apr 11, 2011: Enigma Announces Start Of US Clinical Trials For Influenza A/B Detection Assay
    Apr 11, 2011: Enigma Announces Start Of US Clinical Trials For Influenza A/B Detection Assay
    Oct 19, 2010: Enigma Diagnostics' Patents Maintained By UK IPO
    Apr 22, 2010: Enigma Diagnostics To Showcase Enigma ML At InnovHealth Summit 2010 In Abu Dhabi
    Apr 19, 2010: Enigma Diagnostics Gets US Patent Grant Covering Amplification Consumables
    Mar 04, 2010: Enigma Diagnostics Appoints Joel Centeno As VP Regulatory & Quality, US
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Enigma Diagnostics Limited Pipeline Products and Clinical Trials Overview
    Enigma Diagnostics Limited Pipeline Products by Equipment Type
    Enigma Diagnostics Limited Pipeline Products by Indication
    Enigma Diagnostics Limited, Key Facts
    Enigma Diagnostics Limited, Major Products and Services
    Enigma Diagnostics Limited Number of Pipeline Products by Development Stage
    Enigma Diagnostics Limited Pipeline Products Summary by Development Stage
    Enigma ML - C. Difficile/Norovirus - Product Status
    Enigma ML - C. Difficile/Norovirus - Product Description
    Enigma ML - CT/NG - Product Status
    Enigma ML - CT/NG - Product Description
    Enigma ML - HPV - Product Status
    Enigma ML - HPV - Product Description
    Enigma ML - MRSA - Product Status
    Enigma ML - MRSA - Product Description
    Enigma ML - Rhinovirus - Product Status
    Enigma ML - Rhinovirus - Product Description
    Enigma ML - Tuberculosis DST Detestion Assay - Product Status
    Enigma ML - Tuberculosis DST Detestion Assay - Product Description
    Enigma ML System - Product Status
    Enigma ML System - Product Description
    Enigma ML System - FluAB-RSV Diagnostic Assay - Product Status
    Enigma ML System - FluAB-RSV Diagnostic Assay - Product Description
    Enigma XL System - Product Status
    Enigma XL System - Product Description
    MDx Infectious Disease Assay - Product Status
    MDx Infectious Disease Assay - Product Description
    ResonSense MDR-TB Assay - Product Status
    ResonSense MDR-TB Assay - Product Description
    Enigma Diagnostics Limited, Key Employees

    LIST OF FIGURES

    Enigma Diagnostics Limited Pipeline Products by Equipment Type
    Enigma Diagnostics Limited Pipeline Products by Development Stage
    Skip to top


    Ask Your Question

    Enigma Diagnostics Limited - Product Pipeline Analysis, 2016 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: